Ligand-protein docking: cancer research at the interface between biology and chemistry.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current Medicinal Chemistry

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/0929867033457809PMID 12678780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites.

  2003cited by this paper
• Pattern recognition and massively distributed computing

  2002cited by this paper
• Molecular dynamics simulations of biomolecules

  2002cited by this paper
• CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.

  2002cited by this paper
• Molecular docking and 3D-QSAR studies on gag peptide analogue inhibitors interacting with human cyclophilin A.

  2002cited by this paper
• A review of protein-small molecule docking methods

  2002cited by this paper
• FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.

  2002cited by this paper
• A small-molecule inhibitor of the ribonucleolytic activity of human angiogenin that possesses antitumor activity

  2002cited by this paper
• Prediction of structure and function of G protein-coupled receptors

  2002cited by this paper
• Inhibitory mode of 1,5-diarylpyrazole derivatives against cyclooxygenase-2 and cyclooxygenase-1: molecular docking and 3D QSAR analyses.

  2002cited by this paper
• Discovery of new inhibitors of aldose reductase from molecular docking and database screening.

  2002cited by this paper
• Concept and prototype of protein-ligand docking simulator with force feedback technology

  2002cited by this paper
• Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B.

  2002cited by this paper
• Enhanced docking with the mining minima optimizer: Acceleration and side‐chain flexibility

  2002cited by this paper
• Molecular dynamics and free energy analyses of cathepsin D-inhibitor interactions: insight into structure-based ligand design.

  2002cited by this paper
• Ligand-induced changes in the binding sites of proteins

  2002cited by this paper
• A novel approach for characterizing protein ligand complexes: molecular basis for specificity of small-molecule Bcl-2 inhibitors.

  2002cited by this paper
• A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor

  2002cited by this paper
• Computer-aided design of selective COX-2 inhibitors: comparative molecular field analysis, comparative molecular similarity indices analysis, and docking studies of some 1,2-diarylimidazole derivatives.

  2002cited by this paper
• Docking of flexible molecules using multiscale ligand representations.

  2002cited by this paper
• Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors.

  2002cited by this paper
• Binding affinities and protein ligand complex geometries of nucleotides at the F1 part of the mitochondrial ATP synthase obtained by ligand docking calculations

  2002cited by this paper
• Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model.

  2002cited by this paper
• Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach.

  2002cited by this paper
• TreeDock: a tool for protein docking based on minimizing van der Waals energies.

  2002cited by this paper
• A new test set for validating predictions of protein–ligand interaction

  2002cited by this paper
• Binding affinity prediction of novel estrogen receptor ligands using receptor-based 3-D QSAR methods.

  2002cited by this paper
• Consensus scoring for ligand/protein interactions.

  2002cited by this paper
• Identification of ligand binding sites on proteins using a multi-scale approach.

  2002cited by this paper
• Ligand-protein database: linking protein-ligand complex structures to binding data.

  2001cited by this paper
• Binding mode prediction for a flexible ligand in a flexible pocket using multi-conformation simulated annealing pseudo crystallographic refinement.

  2001cited by this paper
• A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells.

  2001cited by this paper
• Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells.

  2001cited by this paper
• Improved scoring of ligand-protein interactions using OWFEG free energy grids.

  2001cited by this paper
• Protein docking using continuum electrostatics and geometric fit.

  2001cited by this paper
• A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein-ligand binding affinities.

  2001cited by this paper
• FlexE: efficient molecular docking considering protein structure variations.

  2001cited by this paper
• Ligand-receptor docking with the Mining Minima optimizer

  2001cited by this paper
• Statistical potentials and scoring functions applied to protein-ligand binding.

  2001cited by this paper
• Molecular models of N-benzyladriamycin-14-valerate (AD 198) in complex with the phorbol ester-binding C1b domain of protein kinase C-delta.

  2001cited by this paper
• Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP kinase protein system.

  2001cited by this paper
• Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors

  2001cited by this paper
• Human type 10 17 beta-hydroxysteroid dehydrogenase: molecular modelling and substrate docking.

  2001cited by this paper
• Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects.

  2001cited by this paper
• Metabolism of sirolimus and its derivative everolimus by cytochrome P450 3A4: insights from docking, molecular dynamics, and quantum chemical calculations.

  2001cited by this paper
• Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis.

  2001cited by this paper
• Fully flexible low-mode docking: application to induced fit in HIV integrase.

  2001cited by this paper
• A virtual high throughput screen for high affinity cytochrome P450cam substrates. Implications for in silico prediction of drug metabolism

  2001cited by this paper
• Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4

  2001cited by this paper
• Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase.

  2001cited by this paper
• How Does Consensus Scoring Work for Virtual Library Screening? An Idealized Computer Experiment

  2001cited by this paper
• State of the art in studying protein folding and protein structure prediction using molecular dynamics methods.

  2001cited by this paper
• DARWIN: A program for docking flexible molecules

  2000cited by this paper
• Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations.

  2000cited by this paper
• Knowledge-based scoring function to predict protein-ligand interactions.

  2000cited by this paper
• Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads.

  2000cited by this paper
• Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells.

  2000cited by this paper
• SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

  2000cited by this paper
• Ligand responsiveness in human prostate cancer: structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors.

  2000cited by this paper
• A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.

  2000cited by this paper
• Position-specific trapping of topoisomerase I-DNA cleavage complexes by intercalated benzo[a]- pyrene diol epoxide adducts at the 6-amino group of adenine.

  2000cited by this paper
• A method for including protein flexibility in protein-ligand docking: improving tools for database mining and virtual screening.

  2000cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.

  1999cited by this paper
• A general and fast scoring function for protein-ligand interactions: a simplified potential approach.

  1999cited by this paper
• Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.

  1999cited by this paper
• Docking of cationic antibiotics to negatively charged pockets in RNA folds.

  1999cited by this paper
• Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein.

  1999cited by this paper
• Determinants of ligand binding to cAMP-dependent protein kinase.

  1999cited by this paper
• The role of waters in docking strategies with incremental flexibility for carbohydrate derivatives: heat-labile enterotoxin, a multivalent test case.

  1999cited by this paper
• Molecular docking studies on interaction of diverse retinol structures with human alcohol dehydrogenases predict a broad role in retinoid ligand synthesis.

  1999cited by this paper
• MCDOCK: A Monte Carlo simulation approach to the molecular docking problem

  1999cited by this paper
• Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins.

  1999cited by this paper
• Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton′s Tyrosine Kinase (BTK), LFM-A13 [α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl)Propenamide]*

  1999cited by this paper
• Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations.

  1999cited by this paper
• The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, thermolysin and neuraminidase

  1999cited by this paper
• Structure-based design of potent inhibitors of EGF-receptor tyrosine kinase as anti-cancer agents.

  1999cited by this paper
• Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.

  1999cited by this paper
• Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins.

  1999cited by this paper
• Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design

  1998cited by this paper
• Flexible docking using tabu search and an empirical estimate of binding affinity

  1998cited by this paper
• An example of a protein ligand found by database mining: description of the docking method and its verification by a 2.3 A X-ray structure of a thrombin-ligand complex.

  1998cited by this paper
• Empirical scoring functions. II. The testing of an empirical scoring function for the prediction of ligand-receptor binding affinities and the use of Bayesian regression to improve the quality of the model

  1998cited by this paper
• Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes

  1997cited by this paper
• Molecular basis of agonism and antagonism in the oestrogen receptor

  1997cited by this paper
• Modelling protein docking using shape complementarity, electrostatics and biochemical information.

  1997cited by this paper
• Multiple automatic base selection: Protein–ligand docking based on incremental construction without manual intervention

  1997cited by this paper
• QXP: Powerful, rapid computer algorithms for structure-based drug design

  1997cited by this paper
• Development and validation of a genetic algorithm for flexible docking.

  1997cited by this paper
• Molecular docking to ensembles of protein structures.

  1997cited by this paper
• A comparison of heuristic search algorithms for molecular docking

  1997cited by this paper
• Comparative molecular field analysis of haptens docked to the multispecific antibody IgE(Lb4)

  1996cited by this paper
• Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites.

  1996cited by this paper
• Evolutionary algorithms in computer-aided molecular design

  1996cited by this paper
• Molecular docking using surface complementarity

  1996cited by this paper
• Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

  1995cited by this paper
• Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins.

  1994cited by this paper
• FLOG: A system to select ‘quasi-flexible’ ligands complementary to a receptor of known three-dimensional structure

  1994cited by this paper
• Rational automatic search method for stable docking models of protein and ligand.

  1994cited by this paper
• A shape- and chemistry-based docking method and its use in the design of HIV-1 protease inhibitors

  1994cited by this paper

• Synthesis and anticancer evaluation of tryptanthrin appended spiro-1-nitropyrrolizidine derivatives by the three-component reaction of tryptanthrin, L-proline and β-nitrostyrene

  2025cites this paper
• Synthesis, characterization and bioactivity of new pyridine-2(H)-one, nicotinonitrile, and furo[2,3-b]pyridine derivatives

  2024cites this paper
• Exploring the Therapeutic Potential of Ginkgo biloba Polyphenols in Targeting Biomarkers of Colorectal Cancer: An In-Silico Evaluation.

  2024cites this paper
• Structural, electronic characterization, and antiviral potential of a thiadiazol derivative targeting nucleoprotein of Lassa fever virus: insights from DFT investigation, pharmacokinetic, and molecular docking

  2024cites this paper
• Bioactivity studies and Insilico studies of the isolated compound from ancient plant Vitex negundo against breast cancer.

  2023cites this paper
• Electrostatic Potential Energy in Protein-Drug Complexes.

  2021cites this paper
• Computer Aided Drug Design : An Introduction

  2019cites this paper
• Rational drug design of antineoplastic agents using 3D-QSAR, cheminformatic, and virtual screening approaches.

  2019cites this paper
• NMR-Fragment Based Virtual Screening: A Brief Overview

  2018cites this paper
• Combined approaches to map protein-ligand interactions using NMR and X-ray crystallography

  2018cites this paper
• Rational drug design of antineoplastic agents 1 Rational drug design of antineoplastic agents using 3 D-QSAR , cheminformatic , and virtual screening approaches

  2017cites this paper
• Natural Products as a Potential Enzyme Inhibitors from Medicinal Plants

  2017cites this paper
• In Silico Analysis of Lanostanoids Characterized in Ganoderma Mushrooms (Agaricomycetes) as Potential Ligands of the Vitamin D Receptor.

  2016cites this paper
• Cheminformatics Research at the Unilever Centre for Molecular Science Informatics Cambridge

  2015cites this paper
• In silico pharmacology for a multidisciplinary drug discovery process

  2012cites this paper
• Insilico Analysis and Docking of Imatinib Derivatives Targeting BCR-ABL Oncoprotein for Chronic Myeloid Leukemia

  2012cites this paper
• Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.

  2012cites this paper
• Monoamine oxidase inhibitors: ten years of docking studies.

  2012cites this paper
• Two Birds with One Stone ? Possible Dual-Targeting H 1 N 1 Inhibitors from Traditional Chinese Medicine

  2011cites this paper
• Chemoinformatics and Computational Chemical Biology

  2011influential citation
• Combination of spectroscopic and computational methods to get an understanding of supramolecular chemistry of drugs: from simple host systems to biomolecules.

  2011cites this paper
• Kinetic and docking studies of inhibitors targeting the catalytic zinc in MA clan enzymes

  2011cites this paper
• Two Birds with One Stone? Possible Dual-Targeting H1N1 Inhibitors from Traditional Chinese Medicine

  2011cites this paper
• A combined molecular modeling study on a series of pyrazole/isoxazole based human Hsp90α inhibitors

  2011cites this paper
• Bayesian methods in virtual screening and chemical biology.

  2011cites this paper
• Z-DNA binding proteins as targets for structure-based virtual screening.

  2010cites this paper
• High‐Throughput Virtual Screening Using Quantum Mechanical Probes: Discovery of Selective Kinase Inhibitors

  2010cites this paper
• Drug Design: Docking: a domesday report

  2010cites this paper
• Variation of protein binding cavity volume and ligand volume in protein-ligand complexes.

  2009cites this paper
• Spin diffusion and dynamics studies of the channel forming membrane proteins by solid-state nuclear magnetic resonance

  2009cites this paper
• Protein ligand interaction database (PLID)

  2008cites this paper
• Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model.

  2008cites this paper
• Dynamics of conserved waters in human Hsp90: implications for drug design

  2008cites this paper
• CHAPTER 29 – Preclinical Drug Development

  2007cites this paper
• Cancer immunomics and application of ‘omics’ for cancer management

  2007cites this paper
• The search for drug leads targeted to the beta-secretase: an example of the roles of computer assisted approaches in drug discovery.

  2007cites this paper
• Ligand docking and structure-based virtual screening in drug discovery.

  2007cites this paper
• NAD(P)H:quinone oxidoreductase (NQO1)-directed lavendamycin antitumor agents: Structure-based design, molecular modeling and structure-activity studies

  2007cites this paper
• Artificial intelligence approaches for rational drug design and discovery.

  2007cites this paper
• In silico target fishing: Predicting biological targets from chemical structure

  2006cites this paper
• Drug Discovery Trends

  2006cites this paper
• Dock around the Clock – Current Status of Small Molecule Docking and Scoring

  2006cites this paper
• Handbook of Preformulation: Chemical, Biological, and Botanical Drugs

  2006cites this paper
• Nutraceutical inhibitors of urokinase: potential applications in prostate cancer prevention and treatment.

  2006cites this paper
• Protein kinase Cα and ε small-molecule targeted therapeutics: a new roadmap to two Holy Grails in drug discovery?

  2006cites this paper
• Docking and scoring--theoretically easy, practically impossible?

  2006cites this paper
• Protein kinase Calpha and epsilon small-molecule targeted therapeutics: a new roadmap to two Holy Grails in drug discovery?

  2006cites this paper
• Structure of a synthetic fragment of the lipopolysaccharide (LPS) binding protein when bound to LPS and design of a peptidic LPS inhibitor.

  2005cites this paper
• Proteomics-Based Anticancer Drug Discovery

  2005cites this paper
• Biologically Based Pharmacokinetic and Pharmacodynamic Models of the Skin

  2005cites this paper
• Discovery of cell-permeable non-peptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculations.

  2005cites this paper
• A knowledge-based energy function for protein-ligand, protein-protein, and protein-DNA complexes.

  2005cites this paper
• Progress in cytochrome P450 active site modeling.

  2005cites this paper
• Protein-Protein Docking Methods

  2005cites this paper
• Guided docking approaches to structure-based design and screening.

  2004cites this paper
• Enzymatic and structural characterization of non-peptide ligand-cyclophilin complexes.

  2004cites this paper
• Ligand–protein docking using a quantum stochastic tunneling optimization method

  2004cites this paper
• High-throughput docking as a source of novel drug leads.

  2004cites this paper
• Optimization algorithms and natural computing in drug discovery.

  2004cites this paper
• Automated docking of highly flexible ligands by genetic algorithms: A critical assessment

  2004cites this paper
• Efficient evaluation of binding free energy using continuum electrostatics solvation.

  2004cites this paper
• Expanded Interaction Fingerprint Method for Analyzing Ligand Binding Modes in Docking and Structure-Based Drug Design

  2004cites this paper
• Chemogenomics: an emerging strategy for rapid target and drug discovery

  2004cites this paper
• Virtual screening in structure-based drug discovery.

  2004cites this paper